Hinsch Gylvin Lykke — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hinsch Gylvin Lykke has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Hinsch Gylvin Lykke is a corporate director who, as of June 3, 2026, serves as a director on the board of ProQR Therapeutics N.V., a Netherlands-based biotechnology company focused on RNA therapies. The SEC filing dated 2026-06-03 lists him as a director. No additional publicly disclosed biographical details are provided in the SEC filing context.

Board memberships

• ProQR Therapeutics N.V.

Awards & honors

• Listed as a director on the board of ProQR Therapeutics N.V. in the SEC filing dated 2026-06-03.

Companies — Last 90 Days

• ProQR Therapeutics N.V. (PRQR) — 2 filings, last 2026-06-30

Frequently Asked Questions

Who is Hinsch Gylvin Lykke?

Hinsch Gylvin Lykke is a corporate director who, as of June 3, 2026, serves as a director on the board of ProQR Therapeutics N.V., a Netherlands-based biotechnology company focused on RNA therapies. The SEC filing dated 2026-06-03 lists him as a director. No additional publicly disclosed biographical details are provided in the SEC filing context.…

How many SEC Form 4 filings has Hinsch Gylvin Lykke submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Hinsch Gylvin Lykke's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week